Company Search:
Advanced Search
Sponsored Links
Repligen Corporation Company Snapshot
Repligen Corporation operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Repligen with three other companies in this sector in UNITED STATES : Halozyme Therapeutics, Inc. (2019 sales of $195.99 million of which 36% was Royalties), ANI Pharmaceuticals Inc ($206.55 million of which 100% was Pharmaceutical Products), and 10X Genomics Inc ($245.89 million of which 100% was LABORATORY ANALYTICAL INSTRUMENTS).

Sales Analysis. Repligen reported sales of $270.25 million for the year ending December of 2019. This represents an increase of 39.3% versus 2018, when the company's sales were $194.03 million. Sales at Repligen have increased during each of the previous five years (and since 2014, sales have increased a total of 325%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Repligen Corporation
  Stock Performance Chart for Repligen Corporation
  Stock Data: Recent Stock Performance:
  Current Price (9/11/2020): 144.66
(Figures in U.S. Dollars)
1 Week -0.5%   13 Weeks 0.5%  
4 Weeks 23.8%   52 Weeks 81.4%  
Repligen Corporation Key Data:
  Ticker: RGEN Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2019 Sales 270,245,000
(Year Ending Jan 2020).
Employees: 761
  Currency: U.S. Dollars Market Cap: 7,593,909,919
  Fiscal Yr Ends: December Shares Outstanding: 52,494,884
  Share Type: Common Closely Held Shares: 3,829,368
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.